Clinilabs Opens Phase I Unit in Eatontown, New Jersey
Clinilabs
, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I unit in Southern New Jersey. The 50-bed capacity, 15,000 square foot Specialty Pharma Phase I Unit features semi private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy, and exam rooms.
Since 2001, Clinilabs has successfully completed clinical trials involving healthy, adult human volunteers and specialty patient populations. The staff has accrued experience in over 800 clinical studies, offering clients the service capacity of a big CRO—delivered by an organization that is right-sized and priced for early phase projects. The opening of the New Jersey Specialty Pharma Phase I Unit expands services currently offered at the company’s 50 bed, state-of-the-art, Phase I unit in Manhattan, raising total bed capacity to 100.
“I am pleased to announce the opening of our new unit in Eatontown, New Jersey”, states Gary Zammit, PhD. “This unit allows us to expand our Phase I capacity in two locations, providing first-in-human through end-of-phase II CRO services to our clients. We are now able to enroll larger samples of normal healthy volunteers and patient populations at our two units and at investigator sites worldwide.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
